Posts

Showing posts with the label FTD

Frontotemporal Dementia (FTD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Frontotemporal dementia (FTD) describes a cluster of neurocognitive syndromes that present with impairment of executive functioning, behavioural changes, and a decrease in language proficiency. FTD is the second most common form of dementia in people under the age of 65, and its prevalence is expected to rise as the population ages. FTD is a highly heritable disorder despite varying heritability among different clinical syndromes and subtypes due to various gene mutations. Up to 50% of FTD cases with autosomal-dominant inheritance report a family history of FTD. Clinical diagnoses include behavioural variant FTD (bvFTD); primary progressive aphasia (PPA), which affects language; and disorders that primarily affect movement, progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). The annual prevalence of FTDs varies between 18 to 25 cases per 100,000 population in the USA. Thelansis’s “Frontotemporal Dementia (FTD) Market Outlook, Epidemiology, C...